Cotización F-star Therapeutics, Inc.
Acciones
FSTX
US30315R1077
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20/11/20 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20/11/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,26 % | 108 mil M | |
+9,92 % | 104 mil M | |
+6,26 % | 23,66 mil M | |
-11,35 % | 22,1 mil M | |
-3,29 % | 19,71 mil M | |
-35,98 % | 18,2 mil M | |
-12,95 % | 16,19 mil M | |
+3,58 % | 13,72 mil M | |
+34,32 % | 12,22 mil M |